Chronic Disease Management - HIV/AIDS

Combine all elements completed in previous weeks (Topics 1-4) into one cohesive evidence-based proposal and share the proposal with a leader in your organization. (Appropriate individuals include unit managers, department directors, clinical supervisors, charge nurses, and clinical educators.) Obtain feedback from the leader you have selected and request verification using the Capstone Review Form. For information on how to complete the assignment, refer to "Writing Guidelines" and the "Exemplar of Evidence-Based Practice Capstone Paper." Include a title page, abstract, problem statement, conclusion, reference section, and appendices (if tables, graphs, surveys, diagrams, etc. are created from tools required in Topic 4). Prepare this assignment according to the APA guidelines found in the APA Style Guide, located in the Student Success Center. This assignment uses a rubric. Please review the rubric prior to beginning the assignment to become familiar with the expectations for successful completion. ------------------------------------------------------------------------------------------------------------------------ Note: Below are the attached Topics from Week 1-4. Week 1: (a) Developing a question- PICOT (b) Identifying a Problem (c) Selecting sources of literature wk 1 will be attached because this is not from your orders. Week 2: (a) Incorporating Theory - order no. 00031188 (b) Review of the literature - order no. 00031190 Week 3: Developing an implementation Plan - order no. 00031347 Week 4: (a) Developing an Evaluation Plan - order no. 00031522 (b) Disseminating Evidence - order no. 00031524. I am also attaching the WRITING GUIDELINES for the NRS-441V: Capstone Project. Use this writing guidelines for this order. * Also use the format NRS-441V: Capstone Project (Exemplar of Evidence-Based Practice). Everything is attached. Let me know if there is any problem.

Developing a Question- PICOT

In children exposed to HIV/AIDS (P), low for those infants who are introduced to ARVs during breastfeeding and their mothers introduced to Highly Active antiretroviral drugs (I) during pregnancy and after delivery compared to those infants(C) is HIV virus contraction (O) who are not introduced to ARVs drugs during breastfeeding and whose mothers do not adopt the antiretroviral drugs treatment during pregnancy and after delivery (T)?

 Population: Children exposed to HIV/AIDS who are introduced to antiretroviral drugs during breastfeeding and whose positive pregnant mothers take antiretroviral drugs during the pregnancy and after delivering.

Intervention: The positive pregnant mothers are given highly active antiretroviral drugs during pregnancy and after delivery either for one week or until weaning stage, this reduces the amounts of virus present in the breast milk hence reducing the risk of mother to child transmission in addition, the mothers are advised to continue using the ARVs to lengthen their life expectancy. On the other hand, the infants are breastfed and at the same time taking the antiretroviral drugs. They are also given nevirapine (NVP) once every day until the weaning stage as well as other supplements at their respective times (De Vincenzi, 2011).